The authors investigated the use of plasma neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) as biomarkers for spinal cord degeneration in a cohort of 45 male and 47 female ALD patients [77]. This evidence concerns the gene GFAP and adrenoleukodystrophy.